Back to search
Localized Scleroderma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Localized Scleroderma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Localized Scleroderma trials you may qualify forThis study aims to investigate the effectiveness of BETY, an exercise approach based on the biopsychosocial model, in children and adults diagnosed with sclerod…
Physical functionality and performance are important for individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with s…
It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to addr…
The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the cou…
Despite a number of prospective studies already initiated in the past years, the current epidemiology and course of interstitial lung disease (ILD) and pulmonar…
Localized scleroderma (LS) is a skin disease that can cause complications such as disfigurement and limitation of mobility. Treatment for LS should be initiated…
The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cog…